Jane Street’s Tema Oncology ETF CANC Stock Holding History
Bought
Maintained
Sold
Other funds holding CANC
Jane Street's CANC Position: Q3 2026 in Review
Jane Street increased its Tema Oncology ETF (CANC) stake by 58% in Q3 2026, buying an estimated $673K and bringing the position to 43,450 shares worth $1.83M. The position accounts for ﹤0.01% of the portfolio, ranked #5340.
Jane Street first reported a position in CANC in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.86M in Q2 2024. 17 funds tracked by Wall St. Rank hold CANC as of Q3 2026.
- Jane Street held 43,450 shares of Tema Oncology ETF worth $1.83M as of Q3 2026.
- Jane Street bought 15,913 Tema Oncology ETF shares in Q3 2026, an estimated $673K.
- Tema Oncology ETF made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #5340 holding.
- Jane Street first reported a position in Tema Oncology ETF in Q4 2023 and has held it in 10 quarters since.
- Jane Street's Tema Oncology ETF position peaked at $3.86M in Q2 2024.
- 17 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.